Abnormal expression of the human CD44 gene in early colorectal malignancy with special reference to variant exon 9 (9v).
OBJECTIVE
To examine the expression of CD44 variant exon 9 in early colorectal malignancies.


METHODS
Formalin fixed, paraffin wax embedded tissue sections from 30 cases of tubular adenoma and 35 cases of adenoma with focal carcinoma of the colon were examined immunohistochemically using a monoclonal antibody (MAb 11.24) directed against CD44-9v.


RESULTS
In the normal colorectal mucosa immunoreactivity was confined to the basal part of the crypts and was expressed in less than 10% of crypt cells. CD44-9v was expressed in the superficial part of tubular adenoma with mild atypia in 67% of the cases and in 19% of the tumour cells. The immunoreactivity was observed along the basement membrane in mild atypia, as in the non-neoplastic crypts. In the course of progression to severe atypia the spatial polarity of immunoreactivity was lost, and the extent of CD44-9v expression increased in intensity and in the percentage of positive cases and positive cells. In the carcinomatous lesions of adenoma with focal carcinoma, 94% of the cases and 44% of the tumour cells were positive for CD44-9v protein.


CONCLUSIONS
CD44-9v may be overexpressed at the early stage of colorectal tumorigenesis and this increase continues throughout the course of the disease.
Kawahara
K
K
Department of Pathology, Okayama University Medical School, Japan.
Yoshino
T
T
Kawasaki
N
N
Miyake
K
K
Akagi
T
T
D000236:Adenoma / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002277:Carcinoma / Q000276:immunology*; D015179:Colorectal Neoplasms / Q000276:immunology*; D005091:Exons; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis*; D007150:Immunohistochemistry; D007413:Intestinal Mucosa / Q000276:immunology
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D018960:Hyaluronan Receptors